title: TRIM30 alpha negatively regulates TLR-mediated NF-kappa B activation by targeting TAB2 and TAB3 for degradation.
abstract: Toll-like receptor (TLR) signaling is pivotal to innate and adaptive immune responses and must be tightly controlled. The mechanisms of TLR signaling have been the focus of extensive studies. Here we report that the tripartite-motif protein TRIM30alpha, a RING protein, was induced by TLR agonists and interacted with the TAB2-TAB3-TAK1 adaptor-kinase complex involved in the activation of transcription factor NF-kappaB. TRIM30alpha promoted the degradation of TAB2 and TAB3 and inhibited NF-kappaB activation induced by TLR signaling. In vivo studies showed that transfected or transgenic mice overexpressing TRIM30alpha were more resistant to endotoxic shock. Consistent with that, in vivo 'knockdown' of TRIM30alpha mRNA by small interfering RNA impaired lipopolysaccharide-induced tolerance. Finally, expression of TRIM30alpha depended on NF-kappaB activation. Our results collectively indicate that TRIM30alpha negatively regulates TLR-mediated NF-kappaB activation by targeting degradation of TAB2 and TAB3 by a 'feedback' mechanism.
authors.affiliation: Laboratory of Molecular Cell Biology, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 200031, China.
authors.forename: Mude
authors.initials: M
authors.lastname: Shi
authors.forename: Weiwen
authors.initials: W
authors.lastname: Deng
authors.forename: Enguang
authors.initials: E
authors.lastname: Bi
authors.forename: Kairui
authors.initials: K
authors.lastname: Mao
authors.forename: Yongyong
authors.initials: Y
authors.lastname: Ji
authors.forename: Guomei
authors.initials: G
authors.lastname: Lin
authors.forename: Xiaodong
authors.initials: X
authors.lastname: Wu
authors.forename: Zhiyun
authors.initials: Z
authors.lastname: Tao
authors.forename: Zhenhu
authors.initials: Z
authors.lastname: Li
authors.forename: Xinfen
authors.initials: X
authors.lastname: Cai
authors.forename: Shuhui
authors.initials: S
authors.lastname: Sun
authors.forename: Charlie
authors.initials: C
authors.lastname: Xiang
authors.forename: Bing
authors.initials: B
authors.lastname: Sun
mesh_terms: D048868:Adaptor Proteins, Signal Transducing / Q000378:metabolism*; D000818:Animals; D002460:Cell Line; D025461:Feedback, Physiological / Q000276:immunology; D005260:Female; D006367:HeLa Cells; D006801:Humans; D047908:Intracellular Signaling Peptides and Proteins / Q000378:metabolism / Q000502:physiology*; D020930:MAP Kinase Kinase Kinases / Q000378:metabolism; D051379:Mice; D008810:Mice, Inbred C57BL; D008822:Mice, Transgenic; D016328:NF-kappa B / Q000037:antagonists & inhibitors / Q000378:metabolism*; D051193:Toll-Like Receptors / Q000819:agonists / Q000037:antagonists & inhibitors / Q000502:physiology*; D000099151:MAP Kinase Kinase Kinase 7
chemical_list: D048868:Adaptor Proteins, Signal Transducing; D047908:Intracellular Signaling Peptides and Proteins; D020930:MAP Kinase Kinase Kinases; D016328:NF-kappa B; D051193:Toll-Like Receptors; D000099151:MAP Kinase Kinase Kinase 7; C528084:TRIM30 alpha protein, mouse; C498761:Tab2 protein, mouse; C528083:Tab3 protein, mouse